You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adjuvant therapy

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Persistent Pulmonary Hypertension of the Newborn, Echocardiography, Respiratory Disease Trial (Nebulized nitroglycerine as

Not yet recruiting
  • Persistent Pulmonary Hypertension of the Newborn
  • +2 more
  • Nebulized nitroglycerine as adjunctive therapy
  • conventional therapy for PPHN
  • (no location specified)
Feb 23, 2023

Obesity; Endocrine; Diabetes Type 2 Trial in Shebin Elkom (Montelukast 10mg, Placebo)

Active, not recruiting
  • Obesity; Endocrine; Diabetes Type 2
  • Montelukast 10mg
  • Placebo
  • Shebin Elkom, Egypt
    Faculty of Medicine
Jan 16, 2023

Early-stage HER2-positive Breast Cancer, Treated With Neratinib

Recruiting
  • Breast Cancer
  • +2 more
    • Bouge, Belgium
      Clinique Saint-Luc Bouge
    Oct 25, 2022

    Bladder Urothelial Carcinoma Trial in Nanjing (primary focal resection plus lymph node dissection, Tislelizumab, Gemcitabine

    Recruiting
    • Bladder Urothelial Carcinoma
    • primary focal resection plus lymph node dissection
    • +2 more
    • Nanjing, Jiangsu, China
      The first affiliated hospital of Nanjing Medical University
    Dec 7, 2022

    Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)

    Recruiting
    • Stage II-III Gastric Cancer
    • MRD-guided therapy
    • Jinan, Shandong, China
    • +4 more
    Nov 27, 2023

    Giant Cell Tumor of Bone Trial in Hangzhou, Lishui, Ningbo (4mg ZOL loaded gentamicin PMMA, gentamicin PMMA)

    Not yet recruiting
    • Giant Cell Tumor of Bone
    • 4mg ZOL loaded gentamicin PMMA
    • gentamicin PMMA
    • Hangzhou, Zhejiang, China
    • +2 more
    Feb 1, 2023

    Colorectal Liver Metastasis Trial in Shanghai (HAIC-FOLFOX combined with Sintilimab and Regorafenib)

    Recruiting
    • Colorectal Liver Metastasis
    • HAIC-FOLFOX combined with Sintilimab and Regorafenib
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 1, 2023

    Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)

    Recruiting
    • Colo-rectal Cancer
    • adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
    • Beijing, China/Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medici
    Aug 4, 2023

    Prematurity, Respiratory Disease, Ventilator Lung; Newborn Trial (Caffeine citrate, Placebo)

    Not yet recruiting
    • Prematurity
    • +2 more
    • Caffeine citrate
    • Placebo
    • (no location specified)
    Sep 3, 2023

    Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic

    Not yet recruiting
    • Head and Neck Cancer
    • +4 more
    • Experimental Observation
    • +3 more
    • Baltimore, Maryland
    • +5 more
    Oct 16, 2023

    Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

    Completed
    • Pancreatic Neuroendocrine Tumor G2
    • Octreotide LAR
    • (no location specified)
    Oct 17, 2023

    Ovarian Reserve and Semen Parameters Evolution During Adjuvant

    Not yet recruiting
    • Melanoma
    • biological sampling
    • Marseille, France
    • +4 more
    Jun 17, 2022

    Hepatocellular Carcinoma Trial in Shanghai (AK104, )

    Not yet recruiting
    • Hepatocellular Carcinoma
    • AK104
    • placebo
    • Shanghai, Shanghai, China
      Zhongshan Hospital, Fudan University
    Aug 4, 2022

    Bronchopulmonary Dysplasia Trial in Tanta (Caffeine, Probiotic Formula)

    Recruiting
    • Bronchopulmonary Dysplasia
    • Tanta, El Gharbia, Egypt
      Tanta University
    Jan 10, 2023

    NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Befotertinib + Icotinib placebo
    • Icotinib + Befotertinib placebo
    • Beijing, China
    • +2 more
    Sep 20, 2023

    Hepatocellular Carcinoma, Adjuvant Therapy Trial in Changsha (TQB2450 injection, Anlotinib HCl capsules)

    Recruiting
    • Hepatocellular Carcinoma
    • Adjuvant Therapy
    • TQB2450 injection
    • Anlotinib hydrochloride capsules
    • Changsha, Hunan, China
      Hunan Provincial People's Hospital (The First Affiliated Hospita
    Apr 28, 2022

    Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

    Not yet recruiting
    • Minimal Residual Disease
    • Esophageal Squamous Cell Carcinoma
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Jun 10, 2023

      Gastric Cancer Trial in Xi'an (Carrelizumab combined with XELOX)

      Recruiting
      • Gastric Cancer
      • Carrelizumab combined with XELOX
      • Xi'an, Shanxi, China
        Wang Nan
      Feb 6, 2023

      Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)

      Recruiting
      • Melanoma Stage III
      • +2 more
      • Encorafenib Pill
      • +2 more
      • Tampa, Florida
        Moffitt Cancer Center
      May 27, 2022

      Breast Cancer, Adjuvant Therapy Trial in Fuzhou (Pyrotinib+Trastuzumab+Capecitabine, Trastuzumab+Pertuzumab/Trastuzumab)

      Recruiting
      • Breast Cancer
      • Adjuvant Therapy
      • Fuzhou, Fujian, China
        Fujian Medical University Union Hospital
      Mar 14, 2022

      Hepatocellular Carcinoma Trial (Donafenib + Tislelizumab)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Donafenib + Tislelizumab
      • (no location specified)
      Sep 15, 2022

      Breast Cancer Trial in Shanghai (The RJBC-APP, Routine post-surgical follow-up)

      Not yet recruiting
      • Breast Cancer
      • The RJBC-APP
      • Routine post-surgical follow-up
      • Shanghai, Please Select, China
        Xiaosong Chen
      Jun 26, 2023

      Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai chest hospital
      Sep 24, 2023

      COVID-19 Trial in Makassar (Eucalyptus Oil, Standard COVID medication)

      Completed
      • COVID-19
      • Eucalyptus Oil
      • Standard COVID medication
      • Makassar, South Sulawesi, Indonesia
        Hasanuddin University Hospital
      May 31, 2022

      Huaier Granules in Postoperative Adjuvant Therapy for Non-small

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Huaier granule
      • Control
      • Shenyang, Liaoning, China
        Liaoning Cancer Hospital & Institute
      Oct 27, 2023